$GBLX
GB SCIENCES INC Stock $gblx

$gblx Overview Financials Valuation SEC Filings Company Website

2021 Form 10-K Financial Statement

#000143774921016461 Filed on July 06, 2021

Income Statement

Concept	2021	2020 Q1	2020
Revenue	$0.00	$0.00
YoY Change		-100.0%
Cost Of Revenue	$0.00	$0.00
YoY Change		-100.0%
Gross Profit	$0.00	$0.00
YoY Change		-100.0%
Gross Profit Margin
Selling, General & Admin	$2.002M	$1.186M	$5.742M
YoY Change	-65.14%	-68.69%	-57.15%
% of Gross Profit
Research & Development	$352.3K		$1.543M
YoY Change	-77.18%		236.41%
% of Gross Profit
Depreciation & Amortization	$34.65K	$35.48K	$541.5K
YoY Change	-93.6%	-84.78%	60.11%
% of Gross Profit
Operating Expenses	$352.3K	$1.186M	$1.543M
YoY Change	-77.18%	-68.69%	236.41%
Operating Profit	-$2.002M	-$1.186M	-$5.742M
YoY Change	-65.14%	-76.84%	-56.47%
Interest Expense	$1.285M	-$166.3K	$1.109M
YoY Change	15.91%	-48.21%	-77.55%
% of Operating Profit
Other Income/Expense, Net	-$1.331M	-$269.2K	$992.5K
YoY Change	-234.14%	1557.45%	-111.94%
Pretax Income	-$3.333M	-$3.626M	-$4.749M
YoY Change	-29.82%	-33.58%	-77.91%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$3.725M	-$8.628M	-$12.37M
YoY Change	-69.9%	73.16%	-47.69%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.01
Diluted Earnings Per Share	-$13.06K	-$31.50K	-$47.88K
COMMON SHARES
Basic Shares Outstanding	285.2M	272.8M
Diluted Shares Outstanding	342.3M

Balance Sheet

Concept	2021	2020 Q1	2020
SHORT-TERM ASSETS
Cash & Short-Term Investments	$793.0K	$151.8K	$151.8K
YoY Change	422.53%	-33.36%	-33.36%
Cash & Equivalents	$793.0K	$2.406K	$151.8K
Short-Term Investments
Other Short-Term Assets	$2.751M	$60.89K	$60.89K
YoY Change	4417.67%	-90.09%	-90.09%
Inventory		$1.446M	$1.446M
Prepaid Expenses
Receivables		$118.0K	$118.0K
Other Receivables		$5.224M	$5.224M
Total Short-Term Assets	$3.544M	$7.001M	$7.001M
YoY Change	-49.38%	101.94%	101.94%
LONG-TERM ASSETS
Property, Plant & Equipment	$25.02K	$37.82K	$5.561M
YoY Change	-99.55%	-99.64%	-76.34%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$5.530M	$91.50K	$91.50K
YoY Change	5944.17%	-92.58%	-92.58%
Total Long-Term Assets	$7.262M	$7.352M	$7.352M
YoY Change	-1.22%	-72.32%	-72.32%
TOTAL ASSETS
Total Short-Term Assets	$3.544M	$7.001M	$7.001M
Total Long-Term Assets	$7.262M	$7.352M	$7.352M
Total Assets	$10.81M	$14.35M	$14.35M
YoY Change	-24.71%	-52.19%	-52.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.412M	$1.913M	$2.560M
YoY Change	-44.82%	39.15%	-16.64%
Accrued Expenses	$1.537M	$813.6K	$1.879M
YoY Change	-18.24%	232.18%	210.41%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$151.9K	$151.9K
YoY Change	-100.0%
Long-Term Debt Due	$3.595M	$5.702M	$5.702M
YoY Change	-36.95%	125.37%	125.37%
Total Short-Term Liabilities	$8.598M	$10.89M	$10.89M
YoY Change	-21.01%	62.18%	62.18%
LONG-TERM LIABILITIES
Long-Term Debt	$292.4K	$3.533M	$3.533M
YoY Change	-91.72%	-42.6%	-42.6%
Other Long-Term Liabilities	$3.389M	$22.52K	$22.52K
YoY Change	14949.38%
Total Long-Term Liabilities	$3.682M	$3.556M	$3.556M
YoY Change	3.54%	-42.23%	-42.23%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.598M	$10.89M	$10.89M
Total Long-Term Liabilities	$3.682M	$3.556M	$3.556M
Total Liabilities	$12.28M	$14.44M	$14.44M
YoY Change	-14.97%	12.23%	-33.52%
SHAREHOLDERS EQUITY
Retained Earnings		-$97.39M
YoY Change		14.92%
Common Stock		$27.55K
YoY Change		14.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.474M	-$88.49K	-$88.49K
YoY Change
Total Liabilities & Shareholders Equity	$10.81M	$14.35M	$14.35M
YoY Change	-24.71%	-52.19%	-52.19%

Cashflow Statement

Concept	2021	2020 Q1	2020
OPERATING ACTIVITIES
Net Income	-$3.725M	-$8.628M	-$12.37M
YoY Change	-69.9%	73.16%	-47.69%
Depreciation, Depletion And Amortization	$34.65K	$35.48K	$541.5K
YoY Change	-93.6%	-84.78%	60.11%
Cash From Operating Activities	-$2.185M	-$231.4K	-$4.480M
YoY Change	-51.22%	-83.38%	-54.55%
INVESTING ACTIVITIES
Capital Expenditures	-$292.7K	-$16.00K	$202.3K
YoY Change	-244.68%	-99.83%	-86.62%
Acquisitions
YoY Change
Other Investing Activities	$4.948M	$16.00K	-$244.6K
YoY Change	-2122.72%	-99.8%	-97.3%
Cash From Investing Activities	$4.656M	$0.00	-$538.8K
YoY Change	-964.08%	-100.0%	-95.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00		$790.2K
YoY Change	-100.0%		-93.07%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$1.476M	345.9K	4.988M
YoY Change	-129.6%	-87.8%	-71.5%
NET CHANGE
Cash From Operating Activities	-$2.185M	-231.4K	-4.480M
Cash From Investing Activities	$4.656M	0.000	-538.8K
Cash From Financing Activities	-$1.476M	345.9K	4.988M
Net Change In Cash	$993.9K	114.5K	-30.29K
YoY Change	-3381.28%	-218.88%	-99.1%
FREE CASH FLOW
Cash From Operating Activities	-$2.185M	-$231.4K	-$4.480M
Capital Expenditures	-$292.7K	-$16.00K	$202.3K
Free Cash Flow	-$1.893M	-$215.4K	-$4.682M
YoY Change	-59.58%	-102.68%	-58.81%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020Q3	dei	Entity Public Float EntityPublicFloat	7400000
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021	dei	Entity Small Business EntitySmallBusiness	true
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Security12g Title Security12gTitle	Common Stock $.0001 Par Value
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021	dei	Document Type DocumentType	10-K
CY2021Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	317012411
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021	gblx	Accrued Interest Capitalized In Convertible Note Principal AccruedInterestCapitalizedInConvertibleNotePrincipal	223094
CY2020	gblx	Accrued Interest Capitalized In Convertible Note Principal AccruedInterestCapitalizedInConvertibleNotePrincipal
CY2021	gblx	Accrued Liabilites Forgiven AccruedLiabilitesForgiven	172500
CY2020	gblx	Accrued Liabilites Forgiven AccruedLiabilitesForgiven
CY2020	gblx	Adjustments To Additional Paid In Capital Induced Note Conversion AdjustmentsToAdditionalPaidInCapitalInducedNoteConversion	127059
CY2020	gblx	Class Of Warrant Or Right Cancelled During Period ClassOfWarrantOrRightCancelledDuringPeriod	5312608
CY2021	gblx	Class Of Warrant Or Right Cancelled During Period ClassOfWarrantOrRightCancelledDuringPeriod	6390125
CY2020	gblx	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	17563000
CY2021	gblx	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	35798809
CY2021	gblx	Class Of Warrant Or Right Expense ClassOfWarrantOrRightExpense	211000
CY2020	gblx	Class Of Warrant Or Right Expense ClassOfWarrantOrRightExpense	103472
CY2020	gblx	Class Of Warrant Or Right Issued During Period ClassOfWarrantOrRightIssuedDuringPeriod	7622780
CY2021	gblx	Class Of Warrant Or Right Issued During Period ClassOfWarrantOrRightIssuedDuringPeriod	43493809
CY2020	gblx	Class Of Warrant Or Right Issued During Period Exercise Price ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice	0.30
CY2021	gblx	Class Of Warrant Or Right Issued During Period Exercise Price ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice	0.10
CY2021	gblx	Cumulative Effect Of New Lease Standard CumulativeEffectOfNewLeaseStandard
CY2020	gblx	Cumulative Effect Of New Lease Standard CumulativeEffectOfNewLeaseStandard	7550
CY2021	gblx	Debt Default Penalty DebtDefaultPenalty	286059
CY2020	gblx	Debt Default Penalty DebtDefaultPenalty
CY2021	gblx	Default Penatly On Convertible Note Payable DefaultPenatlyOnConvertibleNotePayable	286059
CY2020	gblx	Default Penatly On Convertible Note Payable DefaultPenatlyOnConvertibleNotePayable
CY2021	gblx	Depreciation Capitalized In Inventory DepreciationCapitalizedInInventory	532785
CY2020	gblx	Depreciation Capitalized In Inventory DepreciationCapitalizedInInventory	811508
CY2021	gblx	Depreciation Capitalized To Inventory DepreciationCapitalizedToInventory	532785
CY2020	gblx	Depreciation Capitalized To Inventory DepreciationCapitalizedToInventory	811508
CY2021	gblx	Effective Income Tax Rate Reconciliation Adjustments To Valuation Of Deferred Tax Assets EffectiveIncomeTaxRateReconciliationAdjustmentsToValuationOfDeferredTaxAssets	603319
CY2020	gblx	Effective Income Tax Rate Reconciliation Adjustments To Valuation Of Deferred Tax Assets EffectiveIncomeTaxRateReconciliationAdjustmentsToValuationOfDeferredTaxAssets
CY2021	gblx	Effective Income Tax Rate Reconciliation Irc Section280e Amount EffectiveIncomeTaxRateReconciliationIrcSection280eAmount	173045
CY2020	gblx	Effective Income Tax Rate Reconciliation Irc Section280e Amount EffectiveIncomeTaxRateReconciliationIrcSection280eAmount	202877
CY2020	gblx	Exercise Of Warrants For Stock Shares ExerciseOfWarrantsForStockShares	17563000
CY2020	gblx	Exercise Of Warrants For Stock Value ExerciseOfWarrantsForStockValue	1157727
CY2021	gblx	Exercise Of Warrants For Stock Value ExerciseOfWarrantsForStockValue	968023
CY2021	gblx	Gain Loss On Amendment To Line Of Credit GainLossOnAmendmentToLineOfCredit	-650000
CY2020	gblx	Gain Loss On Amendment To Line Of Credit GainLossOnAmendmentToLineOfCredit
CY2020	gblx	Gain Loss On Modification Of Notes Receivable GainLossOnModificationOfNotesReceivable	-1895434
CY2021	gblx	Gain Loss On Modification Of Notes Receivable GainLossOnModificationOfNotesReceivable
CY2021	gblx	Gain Loss On Settlement Of Accounts Payable GainLossOnSettlementOfAccountsPayable	422414
CY2020	gblx	Gain Loss On Settlement Of Accounts Payable GainLossOnSettlementOfAccountsPayable
CY2021	gblx	Income Tax Reconciliation Prior Year Tax Penalties IncomeTaxReconciliationPriorYearTaxPenalties	48076
CY2021	gblx	Increase Decrease In Accrued Liabilities Excluding Interest Payable IncreaseDecreaseInAccruedLiabilitiesExcludingInterestPayable	166828
CY2020	gblx	Increase Decrease In Accrued Liabilities Excluding Interest Payable IncreaseDecreaseInAccruedLiabilitiesExcludingInterestPayable	697429
CY2021	gblx	Induced Dividend From Exercise Of Warrants InducedDividendFromExerciseOfWarrants	2774000
CY2020	gblx	Induced Dividend From Exercise Of Warrants InducedDividendFromExerciseOfWarrants	262240
CY2020	gblx	Induced Dividend From Warrant Exercises InducedDividendFromWarrantExercises
CY2021	gblx	Induced Dividend From Warrant Exercises InducedDividendFromWarrantExercises
CY2021	gblx	Interest Income Receivable And Amortization Of Discount On Note Receivable InterestIncomeReceivableAndAmortizationOfDiscountOnNoteReceivable
CY2020	gblx	Interest Income Receivable And Amortization Of Discount On Note Receivable InterestIncomeReceivableAndAmortizationOfDiscountOnNoteReceivable	509265
CY2021	gblx	Issuance Of Stock For Services IssuanceOfStockForServices
CY2020	gblx	Issuance Of Stock For Services IssuanceOfStockForServices	214000
CY2021	gblx	Issuance Of Warrants To Brokers IssuanceOfWarrantsToBrokers	231335
CY2020	gblx	Issuance Of Warrants To Brokers IssuanceOfWarrantsToBrokers	132914
CY2021Q1	gblx	Operating Loss Carryforwards Not Subject To Expiration OperatingLossCarryforwardsNotSubjectToExpiration	17294940
CY2020Q1	gblx	Operating Loss Carryforwards Subject To Expiration OperatingLossCarryforwardsSubjectToExpiration	34481122
CY2021	gblx	Patent Filing And Drafting Costs Capitalized In Intangible Assets PatentFilingAndDraftingCostsCapitalizedInIntangibleAssets	319939
CY2020	gblx	Patent Filing And Drafting Costs Capitalized In Intangible Assets PatentFilingAndDraftingCostsCapitalizedInIntangibleAssets	247646
CY2021Q1	gblx	Property And Equipment Including Discontinued Operation Accumulated Depreciation And Amortization PropertyAndEquipmentIncludingDiscontinuedOperationAccumulatedDepreciationAndAmortization	1298828
CY2021Q1	gblx	Property And Equipment Including Discontinued Operation Gross PropertyAndEquipmentIncludingDiscontinuedOperationGross	6200097
CY2021Q1	gblx	Property And Equipment Including Discontinued Operation Net PropertyAndEquipmentIncludingDiscontinuedOperationNet	4901269
CY2021	gblx	Property Capitalized Under Operating Leases PropertyCapitalizedUnderOperatingLeases
CY2020	gblx	Property Capitalized Under Operating Leases PropertyCapitalizedUnderOperatingLeases	182624
CY2021	gblx	Repayments Of Principal Notes Payable And Operating Lease Obligation RepaymentsOfPrincipalNotesPayableAndOperatingLeaseObligation	3156014
CY2020	gblx	Repayments Of Principal Notes Payable And Operating Lease Obligation RepaymentsOfPrincipalNotesPayableAndOperatingLeaseObligation	84869
CY2021	gblx	Stock Options Issued For Services StockOptionsIssuedForServices	168000
CY2020	gblx	Stock Options Issued For Services StockOptionsIssuedForServices
CY2021Q1	gblx	Working Capital Deficit WorkingCapitalDeficit	-5054593
CY2020Q1	gblx	Working Capital Deficit WorkingCapitalDeficit	-3884877
CY2021Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1412459
CY2020Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1913049
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	957946
CY2020Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	813618
CY2021Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	746357
CY2021Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	102380770
CY2020Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	97271157
CY2020	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	829737
CY2021	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	543886
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	287260
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	436349
CY2020	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	132914
CY2021	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	231335
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	776122
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1150995
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	164049941
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	158404020
CY2021Q1	us-gaap	Assets Assets	10806054
CY2020Q1	us-gaap	Assets Assets	14352868
CY2021Q1	us-gaap	Assets Current AssetsCurrent	3543855
CY2020Q1	us-gaap	Assets Current AssetsCurrent	7000880
CY2021Q1	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	2494564
CY2020Q1	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	1755275
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	793040
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2406
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	793040
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2406
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	151766
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	182055
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1145633
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	993867
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-30289
CY2021	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	-161768
CY2020	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	741655
CY2021	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-103729
CY2020	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-446922
CY2021	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-118644
CY2020	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-2215434
CY2021Q1	us-gaap	Cash Uninsured Amount CashUninsuredAmount	513901
CY2019Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	99790989
CY2020Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	84538161
CY2021Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	85843036
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000
CY2018Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2018Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000
CY2019Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	315340411
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	275541602
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	315340411
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	275541602
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	31534
CY2020Q1	us-gaap	Common Stock Value CommonStockValue	27554
CY2021Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	292410
CY2020Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable
CY2021	us-gaap	Cost Of Revenue CostOfRevenue
CY2020	us-gaap	Cost Of Revenue CostOfRevenue
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	120451
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit
CY2021	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	160000
CY2020	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	525000
CY2020	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	7583333
CY2021Q1	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	296504
CY2020Q1	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	608580
CY2021Q1	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	154590
CY2020Q1	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	0
CY2021	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount
CY2020	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	4393242
CY2019Q4	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	4393242
CY2021Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	14329450
CY2020Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	14356170
CY2021Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet
CY2020Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet
CY2021Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	10460788
CY2020Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	10625357
CY2021Q1	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	975461
CY2020Q1	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	975461
CY2021Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3131344
CY2020Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2943816
CY2021Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	220795
CY2020Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	136243
CY2021Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	14329450
CY2020Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	14356170
CY2021Q1	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	458938
CY2020Q1	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	324707
CY2021	us-gaap	Depreciation Depreciation	34555
CY2020	us-gaap	Depreciation Depreciation	541462
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	47353
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	125502
CY2021Q1	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	5530415
CY2020Q1	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	6185465
CY2021Q1	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	352593
CY2020Q1	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	149360
CY2021Q1	us-gaap	Due To Officers Or Stockholders Current DueToOfficersOrStockholdersCurrent	84913
CY2020Q1	us-gaap	Due To Officers Or Stockholders Current DueToOfficersOrStockholdersCurrent	586512
CY2021	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.01
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.05
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.036
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2021Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	78000
CY2021Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	43096
CY2020Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	12287
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1706762
CY2020Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1128702
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	467872
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-216954
CY2021	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets
CY2020	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	-147953
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2001617
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5741514
CY2021	us-gaap	Income Tax Expense Benefit Continuing Operations Discontinued Operations Extraordinary Items IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems	168527
CY2020	us-gaap	Income Tax Expense Benefit Continuing Operations Discontinued Operations Extraordinary Items IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems	86837
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.03
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit
CY2021	us-gaap	Gross Profit GrossProfit
CY2020	us-gaap	Gross Profit GrossProfit
CY2021	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-3332850
CY2020	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-4749059
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3332850
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4749059
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-3332850
CY2020	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-4749059
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.01
CY2020	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.02
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-392177
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-8362626
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	26720
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1952653
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-697040
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2178478
CY2020	us-gaap	Lease Cost LeaseCost	754653
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	14407
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	22948
CY2021	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	486145
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-248115
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	739415
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-150137
CY2021	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets
CY2020	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-110485
CY2021	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-501599
CY2020	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	738435
CY2021	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	549703
CY2020	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	464279
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-83750
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	237475
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-20932
CY2021	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense
CY2020	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	127059
CY2021	us-gaap	Interest Expense InterestExpense	1285460
CY2020	us-gaap	Interest Expense InterestExpense	1109031
CY2021	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization
CY2020	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	84354
CY2021	us-gaap	Interest Paid Net InterestPaidNet	241014
CY2020	us-gaap	Interest Paid Net InterestPaidNet	451040
CY2021Q1	us-gaap	Interest Payable Current InterestPayableCurrent	493741
CY2020Q1	us-gaap	Interest Payable Current InterestPayableCurrent	366865
CY2021	us-gaap	Lease Cost LeaseCost	572935
CY2021Q1	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.17
CY2021Q1	us-gaap	Liabilities Liabilities	12279982
CY2020Q1	us-gaap	Liabilities Liabilities	14441362
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10806054
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14352868
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	8598448
CY2020Q1	us-gaap	Liabilities Current LiabilitiesCurrent	10885757
CY2021Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	2054585
CY2020Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	1999062
CY2021Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	3389124
CY2020Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	3555605
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1476432
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4988208
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-1314664
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	4246553
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	4655519
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-538784
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	4759248
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-91862
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2185220
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4479713
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2066576
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2264279
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-12373579
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-3725027
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-738106
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3725027
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12373579
CY2021	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-3332850
CY2020	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-4749059
CY2021	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	-392177
CY2020	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	-7624520
CY2020	us-gaap	Noncontrolling Interest Decrease From Deconsolidation NoncontrollingInterestDecreaseFromDeconsolidation	8707651
CY2020	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	590000
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1331233
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	992455
CY2021Q1	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent
CY2020Q1	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	5224423
CY2021Q1	us-gaap	Notes Payable Current NotesPayableCurrent	3594804
CY2020Q1	us-gaap	Notes Payable Current NotesPayableCurrent	5054728
CY2021Q1	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent
CY2020Q1	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	151923
CY2021Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	771379
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	25022
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	37821
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-2001617
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-5741514
CY2021Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	51776062
CY2020Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	50596940
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-179368
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	74750
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	175000
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	107373
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	188593
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	292675
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	91862
CY2021Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	256251
CY2020Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	18776
CY2021	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt">Reclassifications</div></div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Certain reclassifications have been made to the comparative period amounts in order to conform to the current period presentation. In particular, the assets, liabilities, income, and cash flows of GB Sciences Nevada LLC, GB Sciences Las Vegas, LLC, and GB Sciences Nopah, LLC, have been separated from the comparative period amounts to conform to the current period presentation as discontinued operations as the result of the pending sale of the Company's Nevada operations. The reclassifications had <div style="display: inline; font-style: italic; font: inherit;">no</div> effect on the reported financial position, results of operations or cash flows of the Company.</div></div></div></div></div></div></div></div></div></div></div></div>
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	725000
CY2020	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	2630000
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	790225
CY2021	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	375000
CY2020	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit
CY2021	us-gaap	Proceeds From Sale And Collection Of Notes Receivable ProceedsFromSaleAndCollectionOfNotesReceivable	5051923
CY2020	us-gaap	Proceeds From Sale And Collection Of Notes Receivable ProceedsFromSaleAndCollectionOfNotesReceivable
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1075396
CY2020	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1274790
CY2021	us-gaap	Profit Loss ProfitLoss	-3725027
CY2020	us-gaap	Profit Loss ProfitLoss	-13111685
CY2019Q4	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	1389408
CY2019Q4	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	8000000
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	17155999
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-88494
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1473928
CY2021	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	151923
CY2020	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	352274
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1543397
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-103886232
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-97387205
CY2021	us-gaap	Revenues Revenues
CY2020	us-gaap	Revenues Revenues
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	436349
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	287260
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	0
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	2022443
CY2020Q1	us-gaap	Short Term Investments ShortTermInvestments	0
CY2021Q1	us-gaap	Short Term Investments ShortTermInvestments	0
CY2020	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	2100000
CY2020	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	525000
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	160000
CY2020	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	214000
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	718696
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-1473928
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	-88494
CY2020	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	86837
CY2021Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	761509
CY2020Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	592982
CY2021Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	154914
CY2021	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	48076
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to allowances for doubtful accounts, inventory valuation and standard cost allocations, valuation of initial right-of-use assets and corresponding lease liabilities, valuation of beneficial conversion features in convertible debt, valuation of the assets and liabilities of discontinued operations, stock-based compensation expense, purchased intangible asset valuations, deferred income tax asset valuation allowances, uncertain tax positions, litigation, other loss contingencies, and impairment of long lived assets.  These estimates and assumptions are based on current facts, historical experience and various other factors that the Company believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of costs and expenses that are <div style="display: inline; font-style: italic; font: inherit;">not</div> readily apparent from other sources. The actual results the Company experiences <div style="display: inline; font-style: italic; font: inherit;"> may </div>differ materially and adversely from these estimates.</div></div></div></div></div></div></div></div></div></div></div></div></div></div>
CY2021	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	285190729
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	258450641

Files In Submission

Name	View Source	Status
0001437749-21-016461-index-headers.html	Edgar Link	pending
0001437749-21-016461-index.html	Edgar Link	pending
0001437749-21-016461.txt	Edgar Link	pending
0001437749-21-016461-xbrl.zip	Edgar Link	pending
ex_242304.htm	Edgar Link	pending
ex_242305.htm	Edgar Link	pending
ex_242306.htm	Edgar Link	pending
ex_242307.htm	Edgar Link	pending
ex_242308.htm	Edgar Link	pending
ex_258906.htm	Edgar Link	pending
ex_258907.htm	Edgar Link	pending
ex_258908.htm	Edgar Link	pending
ex_258909.htm	Edgar Link	pending
ex_258910.htm	Edgar Link	pending
ex_258911.htm	Edgar Link	pending
ex_258912.htm	Edgar Link	pending
ex_258913.htm	Edgar Link	pending
ex_258914.htm	Edgar Link	pending
ex_258915.htm	Edgar Link	pending
ex_258916.htm	Edgar Link	pending
ex_258917.htm	Edgar Link	pending
ex_258918.htm	Edgar Link	pending
ex_258919.htm	Edgar Link	pending
ex_258920.htm	Edgar Link	pending
ex_258921.htm	Edgar Link	pending
ex_258922.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
gblx-20210331.xml	Edgar Link	completed
gblx-20210331.xsd	Edgar Link	pending
gblx-20210331_cal.xml	Edgar Link	unprocessable
gblx-20210331_def.xml	Edgar Link	unprocessable
gblx-20210331_lab.xml	Edgar Link	unprocessable
gblx-20210331_pre.xml	Edgar Link	unprocessable
gblx20210331_10k.htm	Edgar Link	pending
logo1.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GBLX
GB SCIENCES INC Stock $gblx

2021 Form 10-K Financial Statement

#000143774921016461 Filed on July 06, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GBLX GB SCIENCES INC Stock $gblx

2021 Form 10-K Financial Statement

#000143774921016461 Filed on July 06, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GBLX
GB SCIENCES INC Stock $gblx